Gabrail Cancer Center Research
Canton, OH
Accepting patients
RENEW
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Activin Receptor IIA Inhibitor
- Placebo
- Closed Label (Masked)
- Phase 3
Accepting patients
AK117/Placebo with Azacitidine
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination With Azacitidine in Patients With Newly Diagnosed Higher-risk Myelodysplastic Syndromes
- Monoclonal Antibody
- CD47
- Closed Label (Masked)
- Randomization
- Placebo
- Phase 2
Accepting patients
MIDAS
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome (MIDAS)
- JAK1 Inhibitor
- ACVR1 Inhibitor
- JAK2 Inhibitor
- Randomization
- Phase 2
Not currently accepting
IBI188
A Study Evaluating the Safety and Efficacy of IBI188 in Combination With AZA in Subjects With Newly Diagnosed MDS
- Monoclonal Antibody
- Phase 1